Advanced Search
PACT Pharma

PACT Pharma

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

Edit ID  20340509 

Golden AI
Golden AI edited on 24 Feb, 2021
Edits made to:
Infobox (+1 properties)
Funding rounds
PACT Pharma Series B round, May 25, 2018
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.